Standard dosage | oral 200 mg to 800 mg twice to three times daily |
Contraindications | concomitant MAOi use, concomitant use of nonnucleoside reverse transcrip- tase inhibitors, hypersensitivity to tricyclic antidepressants (TCA), bone marrow depression; avoid abrupt withdrawal |
Main drug interactions | medications associated with CYP1A2, 2B6, 2C, 3A4 pathways as carbamaze- pine is an inducer. |
Main side effects | rash, myelosuppresion, hepatitis, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion (SIADH), pancreatitis, congenital malformations, seizures, dizziness, drowsiness, blurred vision, impaired coordination |
Special points | carbamazepine is a significant inducer of its own metabolism and serum levels may decrease after chronic use |
Cost | inexpensive |
Standard dosage | 25 mg to 200 mg daily or twice daily |
Contraindications | avoid abrupt withdrawal |
Main drug interactions | carbonic anhydrase inhibitors, oral contraceptives |
Main side effects | metabolic acidosis, nephrolithiasis, osteoporosis, hypokalemia, rash, glauco- ma, paresthesias, weight loss, somnolence, cognitive dysfunction |
Special points | topiramate has significant cognitive dysfunction side effects, regular ophthal- mological exam for glaucoma recommended |
Cost | expensive compared to other oral agents |